| Company profile | Canostix aims to beat cancer simply by diagnosing it so early that it can be already cured today. We realize this by creating a screening platform that addresses the shortcomings of the current diagnostic field. Starting with lung cancer to create the biggest possible impact, our growing database will continuously evolve to the point where most cancers can be screened. Blood samples collected during routine doctor visits will enable earlier detection and differentiation of a variety of cancers. This convenient access to cancer diagnostics will ensure that a majority of the population will undergo screening. Thereby saving countless lives and billions for the healthcare system.
|
| Products & Services | CancerScan is a constantly evolving software solution that upgrades available hardware into top-of-the-line screening machines. This is done through a one-of-a-kind collaboration with leading Indian research institutes and hardware manufacturers, enabling us to fast-track clinical translation by cutting development time and cost by over 70%. CancerScan makes earlier diagnoses possible, which will result in much higher survival chances and less invasive treatments, guaranteeing a much higher quality of life for patients and their family members.
|
| Target group | Canostix will offer its diagnostics software, CancerScan, which works in combination with high-end Raman spectrometers to hospitals and medical laboratories. The target group includes decision-makers, purchasers and head physicians in this target group. Beyond that, Canostix highly values the contact to and input from prescribing physicians in internal medicine and GPs, as well as associations that can endorse the test system.
|
